1. Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story;Tattersfield;Lancet,2004
2. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma;Peters;Lancet,2020
3. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial;Lee;Lancet Respir Med,2020
4. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial;Heaney;Lancet Respir Med,2020
5. Patient preferences for asthma management: a qualitative study;Baggott;BMJ Open,2020